Rizatriptan Benzoate Patent Expiration

1. Maxalt patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5602162

(Pediatric)

ORGANON LLC Imidazole, triazole and tetrazole derivatives
Jul, 2012

(11 years ago)

US5298520

(Pediatric)

ORGANON LLC Triazole containing indole derivatives
Dec, 2012

(11 years ago)




Drug Exclusivity Drug Exclusivity Expiration
New Patient Population(NPP) Dec 16, 2014
Pediatric Exclusivity(PED) Jun 16, 2015

Market Authorisation Date: 29 June, 1998

Treatment: NA

Dosage: TABLET

How can I launch a generic of MAXALT before it's drug patent expiration?
More Information on Dosage

MAXALT family patents

Family Patents

2. Maxalt-mlt patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5602162

(Pediatric)

ORGANON Imidazole, triazole and tetrazole derivatives
Jul, 2012

(11 years ago)

US5298520

(Pediatric)

ORGANON Triazole containing indole derivatives
Dec, 2012

(11 years ago)

US5457895 ORGANON Method of identifying freeze-dried dosage forms
Oct, 2013

(10 years ago)

US5457895

(Pediatric)

ORGANON Method of identifying freeze-dried dosage forms
Apr, 2014

(10 years ago)




Drug Exclusivity Drug Exclusivity Expiration
New Patient Population(NPP) Dec 16, 2014
Pediatric Exclusivity(PED) Jun 16, 2015

Market Authorisation Date: 29 June, 1998

Treatment: NA

Dosage: TABLET, ORALLY DISINTEGRATING

How can I launch a generic of MAXALT-MLT before it's drug patent expiration?
More Information on Dosage

MAXALT-MLT family patents

Family Patents

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

3. Rizafilm patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US9301948 GENSCO Instantly wettable oral film dosage form without surfactant or polyalcohol
Jul, 2034

(10 years from now)




Market Authorisation Date: 14 April, 2023

Treatment: NA

Dosage: FILM

More Information on Dosage

RIZAFILM family patents

Family Patents